In a recent statement, billionaire entrepreneur Elon Musk firmly refuted claims made in a report by the New York Times, which suggested that he has been extensively using the drug ketamine along with other substances. Musk took to the social media platform X to clarify his stance, asserting that he has not been using ketamine for some time.
Elon Musk revealed, “I tried *prescription* ketamine a few years ago and said so on X, so this not even news.” His comments aimed to emphasize that his past use of ketamine was already public knowledge, and he wanted to set the record straight regarding his current stance on the drug.
In his post, Musk acknowledged that ketamine can be beneficial for individuals struggling with mental health issues, stating, “It helps for getting out of dark mental holes.” However, he clarified that he has not taken the medication since his initial experience, indicating a significant shift in his approach to mental wellness.
In response to the article by the New York Times, Musk labeled the publication as “lying,” highlighting his frustration with the media's portrayal of his personal choices. This incident underscores the importance of accurately reporting on public figures and the potential consequences of spreading unverified claims.
Elon Musk's recent remarks serve as a reminder of the ongoing discussions surrounding mental health treatments and the responsible reporting of public figures' health-related choices. As conversations about substances like ketamine continue to evolve, it's crucial to approach such topics with clarity and accuracy to avoid misinformation.
